Consumer protections and rules to promote the march to value-based care are highlights of the massive proposal.
Rating systems for Medicaid managed care plans and protections that make it easier for consumers to move between Medicaid and qualified health plans as their circumstances change are just 2 elements of the massive proposal unveiled today by the Centers for Medicare & Medicaid Services (CMS), which seeks to update rules for the first time since 2002.
Andy Slavitt, acting administrator for CMS, said the proposal’s 3 main aims are to improve transparency and consumer protections, provide better care coordination, and allow states to pursue delivery system reforms that are well under way in Medicare Advantage and in commercial insurance. "A lot has changed in terms of best practices and the delivery of important health services in the managed care field over the last decade," he said.
Overall, the proposed rule seeks to bring Medicaid managed care in line with the goals for value-based reimbursement outlined earlier this year by US Secretary Sylvia Mathews Burwell, who has stated that 50% of Medicare reimbursements will be value-based by 2018.
But Slavitt emphasized that the proposal gives states the flexibility to tailor Medicaid managed care based on local conditions, and that he was “excited to allow states to have continued room for innovation.”
Vikki Wachino, CMS Deputy Administrator/Director of the Center for Medicaid and CHIP Services, filled in details during the briefing with reporters today. Among the highlights:
CMS reports that more than half of all beneficiaries receive some or all of their care through managed care organizations, or MCOs. A year-end review in 2014 by the Kaiser Family Foundation found that some form of Medicaid managed care existed in 39 states, with varying levels of penetration.
Since the last update, the Internet has become a cornerstone of communication for almost everything, and even the very poor are likely to have smartphones, which many have in lieu of land lines. Consumer advocates have decried the lack of requirements for doctors’ directories and other essential pieces of information to be updated continuously online. Consumers and doctors themselves routinely complain about out-of-date lists that limit the ability of Medicaid clients to find a primary care physician, much less specialists.
In a statement, the National Association of Medicaid Directors pledged to work with CMS to ensure ongoing flexibility and innovation. "In many states, Medicaid managed care has become an important tool in transforming a fragmented health care system that pays based on volume into a patient-centered, coordinated model of care that pays based on value. While some states now have decades of experience in Medicaid managed care arrangements, the industry is still evolving in many ways. Therefore, oversight at both the state and federal levels is vitally important to ensuring these goals," the statement said.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More